The association of HLA-DRB1 alleles with rheumatoid arthritis in the Chinese Shantou population: A follow-up study

Biochemistry and Cell Biology

Volumn 85, Issue 2, 2007, Pages 227-238

  Lin, Ling ^a   Chen, Yongsong ^a   Xiao, Zhengyu ^a   Huang, Shaobi ^a   Yang, Ze ^b  

^a SHANTOU UNIVERSITY MEDICAL COLLEGE   (China)

^b BEIJING HOSPITAL   (China)

Author keywords

Arthritis; Disease severity; HLA DRB1 allele; Radiographic progression; Rheumatoid; Susceptibility

Indexed keywords

ANTIBODIES; OLIGONUCLEOTIDES; PATIENT MONITORING; RADIOGRAPHY; REGRESSION ANALYSIS;

ARTHRITIS; DISEASE SEVERITY; RADIOGRAPHIC PROGRESSION; RHEUMATOID;

DISEASES;

AUTOANTIBODY; AZATHIOPRINE; DISEASE MODIFYING ANTIRHEUMATIC DRUG; HLA DR ANTIGEN; METHOTREXATE; SALAZOSULFAPYRIDINE; STEROID;

ADULT; AGED; CHINESE; CLINICAL FEATURE; CONFERENCE PAPER; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE DURATION; DISEASE PREDISPOSITION; DISEASE SEVERITY; FEMALE; FOLLOW UP; FUNCTIONAL STATUS; GENE FREQUENCY; GENOTYPE; HUMAN; HUMAN CELL; HYBRIDIZATION; JOINT RADIOGRAPHY; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; OLIGONUCLEOTIDE PROBE; ONSET AGE; POLYMERASE CHAIN REACTION; RHEUMATOID ARTHRITIS; RISK FACTOR; SEX; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; ALLELES; ARTHRITIS, RHEUMATOID; ASIAN CONTINENTAL ANCESTRY GROUP; CHINA; FEMALE; FOLLOW-UP STUDIES; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HLA-DR ANTIGENS; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED;

EID: 34249695441     PISSN: 08298211     EISSN: None     Source Type: Journal    
DOI: 10.1139/O06-204     Document Type: Conference Paper

References (84)

1. American College of Rheumatology Subcommittee on Rheumatoid Arthritis Guidelines 2002. Guidelines for the management of rheumatoid arthritis: 2002 update. Arthritis Rheum. 46: 328-346. doi:10.1002/art.10148.
2. Anderson, J.J., Wells, G., Verhoeven, A.C., and Felson, D.T. 2000. Factors predicting response to treatment in rheumatoid arthritis: the importance of disease duration. Arthritis Rheum. 43: 22-29. doi:10.1002/1529- 0131(200001)43:1〈22::AID-ANR4〉3.0.CO;2-9.
3. Arnett, F.C., Edworthy, S.M., Bloch, D.A., McShane, D.J., Fries, J.F., Cooper, N.S., et al. 1988. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 31: 315-324.
4. Bathon, J.M., Martin, R.W., Fleischmann, R.M., Tesser, J.R., Schiff, M.H., Keystone, E.C., et al. 2000. A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis. N. Engl. J. Med. 343: 1586-1593. doi:10.1056/NEJM200011303432201.
5. Benazet, J.F., Reviron, D., Mercier, P., Roux, H., and Roudier, J. 1995. HLA-DRB1 alleles associated with rheumatoid arthritis in southern France: absence of extraarticular disease despite the expression of the shared epitope. J. Rheumatol. 22: 607-610.
6. Bignon, J.D., and Fernandez-Vina, M.A. 1997. Protocols of the 12th International Histocompatibility Workshop for typing of HLA class II alleles by DNA amplification by the polymerase chain reaction (PCR) and hybridization with sequence specific oligonucleotide probes (SSOP). In Genetic diversity of HLA: functional and medical implications. Edited by D. Charron. EDK, Paris. pp. 584-595.
7. Boers, M., Verhoeven, A.C., Markusse, H.M., van de Laar, M.A., Westhovens, R., van Denderen, J.C., et al. 1997. Randomised comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritis. Lancet, 350: 309-318. doi:10.1016/S0140-6736(97)01300-7.
8. Boki, K.A., Panayi, G.S., Vaughan, R.W., Drosos, A.A., Moutsopoulos, H.M., and Lanchbury, J.S. 1992. HLA class II sequence polymorphisms and susceptibility to rheumatoid arthritis in Greeks: the HLA-DR shared-epitope hypothesis accounts for the disease in only a minority of Greek patients. Arthritis Rheum. 35: 749-755.
9. Brown, J.H., Jardetzky, T.S., Gorga, J.C., Stern, L.J., Urban, R.G., Strominger, J.L., and Wiley, D.C. 1993. Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1. Nature (London), 364: 33-39. doi:10.1038/364033a0.
10. Buckland-Wright, J.C., Clarke, G.S., Chikanza, I.C., and Graname, R. 1993. Quantitative microfocal radiography detects changes in erosion area in patients with early rheumatoid arthritis treated with myocrisine. J. Rheumatol. 20: 243-247.
11. Clarke, A.E., St-Pierre, Y., Joseph, L., Penrod, J., Sibley, J.T., Haga, M., and Genant, H.K. 2001. Radiographic damage in rheumatoid arthritis correlates with functional disability but not direct medical costs. J. Rheumatol. 28: 2416-2424.
12. Del Rincon, I., Battafarano, D.F., Arroyo, R.A., Murphy, F.T., Fischbach, M., and Escalante, A. 2003. Ethnic variation in the clinical manifestations of rheumatoid arthritis: role of HLA-DRB1 alleles. Arthritis Rheum. 49: 200-208. doi:10.1002/art.11000.
13. Despres, N., Boire, G., Lopez-Longo, F.J., and Menard, H.A. 1994. The Sa system: a novel antigen-antibody system specific for rheumatoid arthritis. J. Rheumatol. 21: 1027-1033.
14. de Vries, N., Tijssen, H., van Riel, P.L., and van de Putte, L.B. 2002. Reshaping the shared epitope hypothesis: HLA-associated risk for rheumatoid arthritis is encoded by amino acid substitutions at positions 67-74 of the HLA-DRB1 molecule. Arthritis Rheum. 46: 921-928. doi:10.1002/art.10210.
15. Egsmose, C., Lund, B., Borg, G., Pettersson, H., Berg, E., Brodin, U., and Trang, L. 1995. Patients with rheumatoid arthritis benefit from early 2nd line therapy: 5 year follow-up of a prospective double blind placebo controlled study. J. Rheumatol. 22: 2208-2213.
16. Eyre, S., Barton, A., Shephard, N., Hinks, A., Brintnell, W., MacKay, K., et al. 2004. Investigation of susceptibility loci identified in the UK rheumatoid arthritis whole-genome scan in a further series of 217 UK affected sibling pairs. Arthritis Rheum. 50: 729-735. doi.10.1002/art.20039.
17. Fu, X.T., Bono, C.P., Woulfe, S.L., Swearingen, C., Summers, N.L., Sinigaglia, F., et al. 1995. Pocket 4 of the HLA-DR (alpha, beta 1*0401) molecule is a major determinant of T cells recognition of peptide. J. Exp. Med. 181: 915-926. doi:10.1084/jem.181.3.915.
18. Fuji, K., Tsuji, M., Murata, K., Terato, K., Shimozuru, Y., and Nagai, Y. 1989. An improved enzyme-linked immunosorbent assay of anti-collagen antibodies in human serum. J. Immunol. Methods, 124: 63-70.
19. Gao, X., Gazit, E., Livneh, A., and Stastny, P. 1991. Rheumatoid arthritis in Israeli Jews: shared sequences in the third hypervariable region of DRB1 alleles are associated with susceptibility. J. Rheumatol. 18: 801-803.
20. Genant, H.K. 1983. Methods of assessing radiographic change in rheumatoid arthritis. Am. J. Med. 75: 35-47.
21. Gorman, J.D., and Criswell, L.A. 2002. The shared epitope and severity of rheumatoid arthritis. Rheum. Dis. Clin. North Am. 28: 59-78. doi:10.1016/S0889-857X(03)00069-3.
22. Gorman, J.D., Lum, R.F., Chen, J.J., Suarez-Almazor, M.E., Thomson, G., and Criswell, L.A. 2004. Impact of shared epitope genotype and ethnicity on erosive disease: a meta-analysis of 3,240 rheumatoid arthritis patients. Arthritis Rheum. 50: 400-412. doi:10.1002/art.20006.
23. Goronzy, J.J., Matteson, E.L., Fulbright, J.W., Warrington, K.J., Chang-Miller, A., Hunder, G.G., et al. 2004. Prognostic markers of radiographic progression in early rheumatoid arthritis. Arthritis Rheum. 50: 43-54. doi:10.1002/art.11445.
24. Gregersen, P.K., Silver, J., and Winchester, R.J. 1987. The shared epitope hypothesis: An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis patients. Arthritis Rheum. 30: 1205-1213.
25. Harney, S., Newton, J., Milicic, A., Brown, M.A., and Wordsworth, B.P. 2003. Non-inherited maternal HLA alleles are associated with rheumatoid arthritis. Rheumatology, 42: 171-174. doi:10.1093/rheumatology/keg059.
26. Hassfeld, W., Steiner, G., Hartmuth, K., Kolarz, G., Scherak, O., Grainger, W., et al. 1989. Demonstration of a new antinuclear antibody (anti-RA33) that is highly specific for rheumatoid arthritis. Arthritis Rheum. 32: 1515-1520.
27. Higami, K., Hakoda, M., Matsuda, Y., Ueda, H., and Kashiwazaki, S. 1997. Lack of association of HLA-DRB1 genotype with radiologic progression in Japanese patients with early rheumatoid arthritis. Arthritis Rheum. 40: 2241-2247.
28. Higuchi, R. 1989. Sample and rapid preparation of samples for PCR. In PCR technology: principles and applications for DNA amplification. Edited by H.A. Erlich. New York. Stockton Press. pp. 31-38.
29. Hochberg, M.C., Chang, R.W., Dwosh, I., Lindsey, S., Pincus, T., and Wolfe, F. 1992. The American College of Rheumatology 1991 revised criteria for the classification of global function status in rheumatoid arthritis. Arthritis Rheum. 35: 498-502.
30. Ioannidis, J.P., Tarassi, K., Papadopoulos, I.A., Voulgari, P.V., Boki, K.A., Papasteriades, C.A., and Drosos, A.A. 2002. Shared epitopes and rheumatoid arthritis: disease associations in Greece and meta-analysis of mediterranean European populations. Semin. Arthritis Rheum. 31: 361-370. doi:10.1053/sarh.2002.31725.
31. Kapitany, A., Zilahi, E., Szanto, S., Szucs, G., Szabo, Z., Vegvari, A., et al. 2005. Association of rheumatoid arthritis with HLA-DR1 and HLA-DR4 in Hungary. Ann. N. Y. Acad. Sci. 1051: 263-270. doi:10.1196/annals.1361. 067.
32. Karlson, E.W., Lee, I.M., Cook, N.R., Manson, J.E., Buring, J.E., and Hennekens, C.H. 1999. A retrospective cohort study of cigarette smoking and risk of rheumatoid arthritis in female health professionals. Arthritis Rheum. 42: 910-917. doi:10.1002/1529-0131(199905)42:5〈910::AID-ANR9〉3. 0.CO;2-D.
33. Kim, H.Y., Min, J.K., Yang, H.I., Park, S.H., Hong, Y.S., Jee, W.H., et al. 1997. The impact of HLA-DRB1*0405 on disease severity in Korean patients with seropositive rheumatoid arthritis. Br. J. Rheumatol. 36: 440-443. doi:10.1093/rheumatology/36.4.440.
34. Kinikli, G., Ates, A., Turgay, M., Akay, G., Kinikli, S., and Tokgoz, G. 2003. HLA-DRB1 genes and disease severity in rheumatoid arthritis in Turkey. Scand. J. Rheumatol. 32: 277-280.
35. Kirwan, J.R. 2001. Links between radiological change, disability, and pathology in rheumatoid arthritis. J. Rheumatol. 28: 881-886.
36. Koh, W.H., Chan, S.H., Lin, Y.N., and Boey, M.L. 1997. Association of HLA-DRB1* 0405 with extraarticular manifestations and erosions in Singaporean Chinese with rheumatoid arthritis. J. Rheumatol. 24: 629-632. PMID.9101492.
37. Landewe, R.B., Boers, M., Verhoeven, A.C., Westhovens, R., van de Laar, M.A., Markusse, H.M., et al. 2002. COBRA combination therapy in patients with early rheumatoid arthritis: long-term structural benefits of a brief intervention. Arthritis Rheum. 46: 347-356. doi:10.1002/art.10083.
38. Lee, D.M., and Weinblatt, M.E. 2001. Rheumatoid arthritis. Lancet, 358: 903-911. doi:10.1016/S0140-6736(01)06075-5.
39. Lee, H.S., Lee, K.W., Song, G.G., Kim, H.A., Kim, S.Y., and Bae, S.C. 2004. Increased susceptibility to rheumatoid arthritis in Koreans heterozygous for HLA-DRB1*0405 and *0901. Arthritis Rheum. 50: 3468-3475. doi:10.1002/art.20608.
40. MacGregor, A.J., Snieder, H., Rigby, A.S., Koskenvuo, M., Kaprio, J., and Aho, K. 2000. Characterizing the quantitative genetic contribution to rheumatoid arthritis using data from twins. Arthritis Rheum. 43: 30-37. doi:10.1002/1529-0131(200001)43:1〈30::AID-ANR5〉3.0.CO;2-B.
41. Marsh, S.G. 1998. HLA class II region sequences, 1998. Tissue Antigens, 51: 467-507.
42. Mattey, D.L., Hassell, A.B., Dawes, P.T., Ollier, W.E., and Hajeer, A. 1999. Interaction between tumor necrosis factor microsatellite polymorphisms and the HLA-DRB1 shared epitope in rheumatoid arthritis: influence on disease outcome. Arthritis Rheum. 42: 2698-2704. doi:10.1002/1529-0131(199912)42: 12〈2698::AID-ANR28〉3.0.CO;2-S.
43. Milicic, A., Lee, D., Brown, M.A., Darke, C., and Wordsworth, B.P. 2002. HLA-DR/DQ haplotype in rheumatoid arthritis: novel allelic associations in UK Caucasians. J. Rheumatol. 29: 1821-1826.
44. Morgan, A.W., Griffiths, B., Ponchel, F., Montague, B.M., Ali, M., Gardner, P.P., et al. 2000. Fcgamma receptor type IIIA is associated with rheumatoid arthritis in two distinct ethnic groups. Arthritis Rheum. 43: 2328-2334. doi:10.1002/1529-0131(200010)43:10〈2328::AID-ANR21〉3.0. CO;2-Z.
45. Mu, H., Chen, J.J., Jiang, Y., King, M.C., Thomson, G., and Criswell, L.A. 1999. Tumor necrosis factor microsatellite polymorphism is associated with rheumatoid arthritis severity through an interaction with the HLA-DRB1 shared epitope. Arthritis Rheum. 42: 438-442. doi:10.1002/1529-0131(199904)42: 3〈438::AID-ANR7〉3.0.CO;2-F.
46. Munro, R., Hampson, R., McEntegart, A., Thomson, E.A., Madhok, R., and Capell, H. 1998. Improved functional outcome in patients with early rheumatoid arthritis treated with intramuscular gold: results of a five year prospective study. Ann. Rheum. Dis. 57: 88-93.
47. Nichol, F.E., and Woodrow, J.C. 1981. HLA-DR antigens in Indian patients with rheumatoid arthritis. Lancet, 1: 220-221.
48. Nienhuis, R.L. and Mandema, E. 1964. A new serum factor in patients with rheumatoid arthritis: the antipericnulear factor. Ann. Rheum. Dis. 23: 302-305.
49. O'Dell, J.R. 2002. Treating rheumatoid arthritis early: a window of opportunity? Arthritis Rheum. 46: 283-285. doi:10.1002/art.10092.
50. Osorio Y Fortea, J., Bukulmez, H., Petit-Teixeira, E., Michou, L., Pierlot, C., et al. 2004. Dense genome-wide linkage analysis of rheumatoid arthritis, including covariates. Arthritis Rheum. 50: 2757-2765. doi:10.1002/art.20458.
51. Qiu, C., Zhao, Y., Tao, Z., Zhu, X., Xu, Z., and Dong, Y. 1995. Rapid HLA-DRBl generic typing by PCR-SSP method. Chin. Med. Sci. J. 10: 34-37.
52. Ruiz-Morales, J.A., Vargas-Alarcon, G., Flores-Villanueva, P.O., Villarreal-Garza, C., Hernandez-Pacheco, G., Yamamoto-Furusho, J.K., et al. 2004. HLA-DRB1 alleles encoding the "shared epitope" are associated with susceptibility to developing rheumatoid arthritis whereas HLA-DRB1 alleles encoding an aspartic acid at position 70 of the beta-chain are protective in Mexican Mestizos. Hum. Immunol. 65: 262-269. doi:10.1016/j.humimm.2003. 12.009.
53. Saag, K.G., Cerhan, J.R., Kolluri, S., Ohashi, K., Hunninghake, G.W., and Schwartz, D.A. 1997. Cigarette smoking and rheumatoid arthritis severity. Ann. Rheum. Dis. 56: 463-469.
54. Sanchez, B., Moreno, I., Magarino, R., Garzon, M., Gonzalez, M.F., Garcia, A., and Nunez-Roldan, A. 1990. HLA-DRw10 confers the highest susceptibility to rheumatoid arthritis in a Spanish population. Tissue Antigens, 36: 174-176.
55. Schiff, B., Mizrachi, Y., Orgad, S., Yaron, M., and Gazit, E. 1982. Association of HLA-Aw31 and HLA-DR1 with adult rheumatoid arthritis. Ann. Rheum. Dis. 41: 403-404.
56. Scott, D.L. 2002. The diagnosis and prognosis of early arthritis: rationale for new prognostic criteria. Arthritis Rheum. 46: 286-290. doi:10.1002/art.10134.
57. Scott, D.L., Pugner, K., Kaarela, K., Doyle, D.V., Woolf, A., Holmes, J., and Hieke, K. 2000. The links between joint damage and disability in rheumatoid arthritis. Rheumatology (Oxford), 39: 122-132. doi:10.1093/rheumatology/ 39.2.122.
58. Seglias, J., Li, E.K., Cohen, M.G., Wong, R.W.S., Potter, P.K., and So, A.K. 1992. Linkage between rheumatoid arthritis susceptibility and the presence of HLA-DR4 and DR beta allelic third hypervariable region sequences in southern Chinese person. Arthritis Rheum. 35: 163-167.
59. Sharp, J.T., Young, D.Y., Bluhm, G.B., Brook, A., Brower, A.C., Corbett, M., et al. 1985. How many joints in the hands and wrists should be included in a score of radiologic abnormalities used to assess rheumatoid arthritis? Arthritis Rheum. 28: 1326-1335.
60. Silman, A.J., Newman, J., and MacGregor, A.J. 1996. Cigarette smoking increases the risk of rheumatoid arthritis: results from a nationwide study of disease-discordant twins. Arthritis Rheum. 39: 732-735.
61. Sokka, T., and Pincus, T. 2001. Markers for work disability in rheumatoid arthritis. J. Rheumatol. 28: 1718-1722.
62. Stastny, P. 1978. Association of the B-cell alloantigen DRw4 with rheumatoid arthritis. N. Engl. J. Med. 298: 869-871.
63. Symmons, D., and Harrison, B. 2000. Early inflammatory polyarthritis: results from the Norfolk arthritis register with a review of the literature, I: risk factors for the development of inflammatory polyarthritis and rheumatoid arthritis. Rheumatology (Oxford), 39: 835-843. doi:10.1093/rheumatology/ 39.8.835.
64. Symmons, D.P., Jones, M.A., Scott, D.L., and Prior, P. 1998. Long-term mortality outcome in patients with rheumatoid arthritis: early presenters continue to do well. J. Rheumatol. 25: 1072-1077.
65. Tan, E.M., Cohen, A.S., Fries, J.F., Masi, A.T., McShane, D.J., Rothfield, N.F., et al. 1982. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 25: 1271-1277.
66. Turesson, C., and Matteson, E.L. 2006. Genetics of rheumatoid arthritis. Mayo Clin. Proc. 81: 94-101.
67. Turesson, C., O'Fallon, W.M., Crowson, C.S., Gabriel, S.E., and Matteson, E.L. 2003. Extra-articular disease manifestations in rheumatoid arthritis: incidence trends and risk factors over 46 years. Ann. Rheum. Dis. 62: 722-727. doi:10.1136/ard.62.8.722.
68. van der Heijde, D.M. 1995. Joint erosions and patients with early rheumatoid arthritis. Br. J. Rheumatol. 34: Suppl. 2, 74-78.
69. Van der Heide, A., Jacobs, J.W., Bijlsma, J.W., Heurkens, A.H., van Booma-Frankfort, C., van der Veen, M.J., et al. 1996. The effectiveness of early treatment with "second-line" antirheumatic drugs: a randomized, controlled trial. Ann. Intern. Med. 124: 699-707.
70. Vehe, R.K., Nepom, G.T., Wilske, K.R., Stage, D., Begovich, A.B., and Nepom, B.S. 1994. Erosive rheumatoid factor negative and positive rheumatoid arthritis are immunogenetically similar. J. Rheumatol. 21: 194-196.
71. Vincent, C., Serre, G., Lapeyre, F., Fourrie, B., Ayrolles, C., and Soleilhavoup, J.P. 1989. High diagnostic value in rheumatoid arthritis of antibodies to the stratum corneum of rat oesophagus epithelium, so-called 'anitkeratin antibodies'. Ann. Rheum. Dis. 48: 712-722.
72. Vitali, C., Bombardieri, S., Jonsson, R., Moutsopoulos, H.M., Alexander, E.L., Carsons, S.E., et al. 2002. Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann. Rheum. Dis. 61: 554-558. doi:10.1136/ard.61.6.554.
73. Wakitani, S., Murata, N., Toda, Y., Ogawa, R., Kaneshige, T., Nishimura, Y., and Ochi, T. 1997. The relationship between HLA-DRB1 alleles and disease subsets of rheumatoid arthritis in Japanese. Br. J. Rheumatol. 36: 630-636. doi:10.1093/rheumatology/36.6.630.
74. Wassmuth, R., and Wagner, U. 2002. Prognostic use of human leukocyte antigen genotyping for rheumatoid arthritis susceptibility, disease course, and clinical stratification. Rheum. Dis. Clin. North Am. 28: 17-37. doi:10.1016/S0889-857X(03)00067-X.
75. Weyand, C.M., and Goronzy, J.J. 1995. Inherited and noninherited risk factors in rheumatoid arthritis. Curr. Opin. Rheumatol. 7: 206-213.
76. Weyand, C.M., Xie, C., and Goronzy, J.J. 1992. Homozygosity for the HLA-DRB1 allele selects for extraarticular manifestations in rheumatoid arthritis. J. Clin. Invest. 89: 2033-2039.
77. Weyand, C.M., Klimiuk, P.A., and Goronzy, J.J. 1998. Heterogeneity of rheumatoid arthritis: from phenotypes to genotypes. Springer Semin. Immunopathol. 20: 5-22. doi:10.1007/BF00831996.
78. Williams, R.C., Jacobsson, L.T., Knowler, W.C., del Puente, A., Kostyu, D., McAuley, J.E., Bennett, P.H., and Pettitt, D.J. 1995. Meta-analysis reveals association between most common class II haplotype in full-heritage Native Americans and rheumatoid arthritis. Hum. Immunol. 42: 90-94. doi:10.1016/0198-8859(94)00079-6.
79. Wolfe, F. 2000. The effect of smoking on clinical, laboratory, and radiographic status in rheumatoid artimtis. J. Rheumatol. 27: 630-637.
80. Wordsworth, B.P., and Bell, J.I. 1992. The immunogenetics of rheumatoid arthritis. Springer Semin. Immunopathol. 14: 59-78.
81. Wordsworth, B.P., Lanchbury, J.S., Sakkas, L.I., Welsh, K.I., Panayi, G.S., and Bell, J.I. 1989. HLA-DR4 subtype frequencies in rheumatoid arthritis indicate that DRB1 is the major susceptibility locus within the HLA class II region. Proc. Natl. Acad. Sci. U.S.A. 86: 10049-10053. doi:10.1073/pnas.86.24.10049.
82. Yelamos, J., Garcia-Lozano, J.R., Moreno, I., Aguilera, I., Gonzalez, M.F., Garcia, A., Nunez-Roldan, A., and Sanchez, B. 1993. Association of HLA-DR4-Dw15 (DRB1*0405) and DR10 with rheumatoid arthritis in a Spanish population. Arthritis Rheum. 36: 811-814.
83. Yuan, G., Shi, G., and Li, Z. 1998. Molecular analysis of HLA-DR beta polymorphism in Han nationality patients with rheumatoid arthritis. Zhonghua Yi Xue Za Zhi, 78: 172-174.
84. Zhao, Y., Dong, Y., Zhu, X., and Qiu, C. 1996. HLA-DRB1 alleles genotyping in patients with rheumatoid arthritis in Chinese. Chin. Med. Sci. J. 11: 232-235.